SOLU-CORTEF

This brand name is authorized in Australia, Canada, Estonia, Finland, Hong Kong, Croatia, Ireland, Israel, Japan, Malta, Netherlands, New Zealand, Singapore, United Kingdom, United States, South Africa

Active ingredients

The drug SOLU-CORTEF contains one active pharmaceutical ingredient (API):

1 Hydrocortisone UNII 50LQB69S1Z - HYDROCORTISONE SODIUM SUCCINATE

Hydrocortisone is the main glucocorticoid secreted by the adrenal cortex. Hydrocortisone is an anti-inflammatory steroid. Its anti-inflammatory action is due to reduction in the vascular component of the inflammatory response and reduction in the formation of inflammatory fluid and cellular exudates. Read about Hydrocortisone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
Solu-Cortef	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
H02AB09	Hydrocortisone	H Systemic hormonal preparations, excl. Sex hormones and insulins → H02 Corticosteroids for systemic use → H02A CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN → H02AB Glucocorticoids
Discover more medicines within H02AB09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 1501B, 1510L, 1511M, 3096Y, 3470P, 3471Q, 5118J, 5119K
Country: CA	Health Products and Food Branch	Identifier(s): 00030600, 00030619, 00030627, 00030635
Country: EE	Ravimiamet	Identifier(s): 1009066
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 439954, 496943, 523273
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 138713, 41828
Country: HK	Department of Health Drug Office	Identifier(s): 00471, 25551
Country: IE	Health Products Regulatory Authority	Identifier(s): 46612
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8129, 8219
Country: JP	医薬品医療機器総合機構	Identifier(s): 2452400D3052, 2452400D6060, 2452400D7040
Country: MT	Medicines Authority	Identifier(s): AA565/67101
Country: NL	Z-Index G-Standaard	Identifier(s): 14043912
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 20400
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 1672
Country: SG	Health Sciences Authority	Identifier(s): 04791P
Country: US	FDA, National Drug Code	Identifier(s): 0009-0005, 0009-0011, 0009-0013, 0009-0016, 0009-0825, 51662-1261, 51662-1262, 55154-3942
Country: ZA	Health Products Regulatory Authority	Identifier(s): G/21.5/201